NF-κB regulates VCAM-1 expression on fibroblast-like synoviocytes

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5990-5997

  Li, Ping ^a   Sanz, Iñaki ^a   O'Keefe, Regis J ^a   Schwarz, Edward M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN;

ANIMAL CELL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; FIBROBLAST; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

EID: 0034119907     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5990     Document Type: Article

References (45)

1. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Rheumatoid arthritis. Cell 85:307.
2. Harris, E. D., Jr. 1990. Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s. Trans. Am. Clin. Climatol. Assoc. 102:260.
3. Feldmann, M., F. M. Brennan, M. Elliott, P. Katsikis, and R. N. Maini. 1994. TNF-α as a therapeutic target in rheumatoid arthritis. Circ. Shock 43:179.
4. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
5. Saxne, T., M. A. Palladino, Jr., D. Heinegård, N. Talal, and F. A. Wollheim. 1988. Detection of tumor necrosis factor-α but not tumor necrosis factor-β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31:1041.
6. Di Giovine, F. S., G. Nuki, and G. W. Duff. 1988. Tumour necrosis factor in synovial exudates. Ann. Rheum. Dis. 47:768.
7. Firestein, G. S., J. M. Alvaro-Gracia, R. Maki, and J. M. Alvaro-Garcia. 1990. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144:3347.
8. Brennan, F. M., D. Chantry, A. Jackson, R. Maini, and M. Feldmann. 1989. Inhibitory effect of TNF-α antibodies on synovial cell IL-1 production in rheumatoid arthritis. Lancet 2:244.
9. Gitter, B. D., J. M. Labus, S. L. Lees, and M. E. Scheetz. 1989. Characteristics of human synovial fibroblast activation by IL-1β and TNF-α. Immunology 66: 196.
10. 2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:2163.
11. 2 production by human synovial cells. J. Clin. Invest. 77:645.
12. Saklatvala, J., S. J. Sarsfield, and Y. Townsend. 1985. Pig interleukin 1: purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever. J Exp. Med. 162:1208.
13. Saklatvala, J. 1986. Tumour necrosis factor-α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547.
14. Bertolini, D. R., G. E. Nedwin, T. S. Bringman, D. D. Smith, and G. R. Mundy. 1986. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319:516.
15. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, and G. Kollias. 1991. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10:4025.
16. Maini, R. N., M. J. Elliott, F. M. Brennan, R. O. Williams, C. Q. Chu, E. Paleolog, P. J. Charles, P. C. Taylor, and M. Feldmann. 1995. Monoclonal anti-TNF-α antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol. Rev. 144:195.
17. Moreland, L. W., S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, et al. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:141.
18. Morales-Ducret, J., E. Wayner, M. J. Elices, J. M. Alvaro-Gracia, N. J. Zvaifler, and G. S. Firestein. 1992. α4/β1 Integrin (VLA-4) ligands in arthritis: vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J. Immunol. 149:1424.
19. Postigo, A. A., R. Garcia-Vicuna, A. Laffon, and F. Sanchez-Madrid. 1993. The role of adhesion molecules in the pathogenesis of rheumatoid arthritis Autoimmunity 16:69.
20. Cronstein, B. N. 1994. Adhesion molecules in the pathogenesis of rheumatoid arthritis. Curr. Opin. Rheumatol. 6:300.
21. Szekanecz, Z., G. Szegedi, and A. E. Koch. 1996. Cellular adhesion molecules in rheumatoid arthritis: regulation by cytokines and possible clinical importance. J. Invest. Med. 44:124.
22. Koch, A. E., M. M. Halloran, C. J. Haskell, M. R. Shah, and P. J. Polverini. 1995. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517.
23. Koch, A. E. 1998. Review: angiogenesis, implications for rheumatoid arthritis. Arthritis Rheum. 41:951.
24. Elices, M. J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M. E. Hemler, and R. R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577.
25. Osborn, L., C. Hession, R. Tizard, C. Vassallo, S. Luhowskyj, G. Chi-Rosso, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203.
26. Firestein, G. S., and N. J. Zvaifler. 1997. Anticytokine therapy in rheumatoid arthritis. N. Engl. J. Med 337:195.
27. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.
28. Baeuerle, P. A., and V. R. Baichwal. 1997. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65:111.
29. Marok, R., P. G. Winyard, A. Coumbe, M. L. Kus, K. Gaffney, S. Blades, P. I. Mapp, C. J. Morris, D. R. Blake, C. Kaltschmidt, and P. A. Baeuerle. 1996. Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum. 39:583.
30. Bondeson, J., B. Foxwell, F. Brennan, and M. Feldmann. 1999. Defining therapeutic targets by using adenovirus: blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc. Natl. Acad. Sci. USA 96:5668.
31. Miagkov, A. V., D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov. 1998. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA 95:13859.
32. Iademarco, M. F., J. J. McQuillan, G. D. Rosen, and D. C. Dean. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:16323.
33. Schwarz, E. M., D. Van Antwerp, and I. M. Verma. 1996. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα. Mol. Cell. Biol. 16:3554.
34. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787.
35. Alvaro-Gracia, J. M., N. J. Zvaifler, and G. S. Firestein. 1990. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86:1790.
36. Schwarz, E. M., C. Badorff, T. S. Hiura, R. Wessely, A. Badorff, I. M. Verma, and K. U. Knowlton. 1998. NFκB mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J. Virol. 72:5654.
37. Schwarz, E. M., P. Krimpenfort, A. Berns, and I. M. Verma. 1997. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11:187.
38. Schwarz, E. M., P. Salgame, and B. R. Bloom. 1993. Molecular regulation of human interleukin 2 and T-cell function by interleukin 4. Proc. Natl. Acad. Sci. USA 90:7734.
39. Dai, Y., E. M. Schwarz, D. Gu, W. W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad Sci. USA 92:1401.
40. Schwarz, E. M., and R. J. O'Keefe. 1998. TNFα/NFκB signaling in periprosthetic osteolysis. Arthritis Rheum. 41:S345.
41. Feldmann, M., F. M. Brennan, R. O. Williams, A. P. Cope, D. L. Gibbons, P. D. Katsikis, and R. N. Maini. 1992. Evaluation of the role of cytokines in autoimmune disease: the importance of TNF-α in rheumatoid arthritis. Prog. Growth Factor Res. 4:247.
42. Koch, A. E., S. L. Kunkel, and R. M. Strieter. 1995. Cytokines in rheumatoid arthritis. J. Invest. Med. 43:28.
43. Liou, H. C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IKB inhibitor system. Curr. Opin. Cell Biol. 5:477.
44. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
45. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.